If you have been diagnosed with aTTP (acquired or immune-mediated thrombotic thrombocytopenic purpura), you may qualify to take part in a 60-minute online interview about your experiences and opinions.

 

Researchers want to know more about people's journeys with aTTP and obtain feedback on educational materials for a treatment. All information and insights shared will remain confidential. Those who complete the interview will receive a check for $125 as a thank you.

​

Please note that we have already included many voices in this research. In order to provide insights from a variety of perspectives and treatment experiences, we are now only seeking individuals who have not received Cablivi (caplacizumab) for treatment of their aTTP.